Large-Scale mRNA Purification Using Porous-Substrate Centrifugation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for purifying messenger RNA (mRNA) are inadequate for large-scale production and are not cost-effective, limiting their use in clinical and commercial applications.
Innovation Solution
A method involving centrifugation with a porous substrate to capture precipitated mRNA, allowing for the purification of large quantities of high-purity mRNA, with yields of at least 80-95% and minimal contamination by prematurely aborted RNA sequences and enzyme reagents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If traditional silica-based column systems or protein extraction methods are used, then mRNA purification is achieved, but the scale is limited to maximally five to ten mg
Solution Approach 1:
The patent extracts mRNA from the reaction mixture by precipitating it with ethanol and centrifuging to form a pellet, separating it from contaminants. This extraction approach enables scaling beyond the limitations of column-based systems while maintaining purification quality.
Solution Approach 2:
The patent changes physical parameters including ethanol concentration (70-100%), temperature (-20°C to room temperature), and centrifugal force to optimize mRNA precipitation and recovery. These parameter adjustments enable scalable purification while maintaining high recovery rates of 80-95%.
2Productivity
If large-scale purification methods are developed, then mRNA production capacity increases, but cost-effectiveness decreases
Solution Approach 1:
The patent employs inexpensive, readily available reagents including ethanol, centrifugation tubes, and standard buffers. These disposable, low-cost materials enable scalable purification without the high expenses associated with specialized chromatography resins or complex equipment, maintaining cost-effectiveness at large scales.
Solution Approach 2:
The purification protocol uses simple precipitation and centrifugation steps that require minimal specialized equipment or expertise. The method is self-contained, using the mRNA's own properties (solubility in ethanol) to drive separation, reducing the need for expensive specialized reagents or equipment.
3Manufacturing precision
If purification purity is increased, then therapeutic quality is improved, but contamination by prematurely aborted RNA sequences and enzyme reagents persists
Solution Approach 1:
The patent performs preliminary DNase treatment to digest DNA templates before mRNA precipitation. This preliminary action removes a major source of contamination before the purification steps, ensuring higher final purity without requiring additional complex purification steps that could reduce yield.
Solution Approach 2:
The patent implements a continuous purification workflow where precipitation, washing with 70% ethanol, and resuspension are performed in sequence without interrupting the mRNA in solution. This continuous action maintains mRNA integrity and prevents recontamination, achieving high purity while minimizing exposure to environmental contaminants.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the production of high-purity mRNA at a large scale, suitable for clinical and commercial uses, with yields of at least 80-95% and minimal contamination, at a cost-effective manner.
Implementation Method 1
centrifuging the suspension in a centrifuge comprising a porous substrate such that the precipitated mRNA is captured on the porous substrate
Implementation Method 2
centrifuging the suspension in a centrifuge comprising a porous substrate such that the precipitated mRNA is captured on the porous substrate
Implementation Method 3
providing a suspension comprising precipitated mRNA
Data Source
AI summary
The present invention relates, in part, to methods for large-scale purification of mRNA. The method includes, at least, a step of centrifuging an mRNA suspension in a centrifuge comprising a porous substrate at a speed sufficient to remove process contaminants and to precipitate purified mRNA composition onto the porous substrate.